Kellen Hirsch

CV Fellow @UofUHealth | Cardiopulmonary Enthusiast | Aspiring Climber | Dog Dad

[Batman-Echo @echo_batman]

Sacubitril/valsartan compared to equivalent/sub-equivalent dose angiotensin receptor blocker or angiotensin-converting enzyme inhibitor in heart failure with reduced ejection fraction: a meta-analysis of randomized trials | Europ Jour of Clinical Pharma https://t.co/dAyMIBjOVK

[Kellen Hirsch @hirsch_kellen]

Also, in this population where ~20% had angina, beta blocker continuation may reduce the risk of admission for angina. Shocking

[Kellen Hirsch @hirsch_kellen]

@RichardAFerraro Interestingly, in this open label trial, it seems that the possible benefit of beta blocker continuation is driven by the cardiac hospitalizations piece of the composite end point…

[Ali Haider MD @yourheartdoc1]

Was a good try

[John Mandrola, MD @drjohnm]

The Study of the Week Is A Study That Did Not Happen

My thoughts on the cancellation of the RECOVER IV trial. It's a story of hubris and duality of interests

https://t.co/yZZm7ZM6mM

[USGS Volcanoes🌋 @USGSVolcanoes]

EQs occurring at median depth of ~3.5 mi (5.7 km) below sea level, about ~4.6 mi (7.4 km) below the crater floor. Small magnitude EQs located beneath #MountStHelens at these depths generally thought to be associated with arrival of additional magma, a process called recharge.

[Kellen Hirsch @hirsch_kellen]

Thrilled to share some recent work diving into #PAH subtype differences via @TheJHLT, @UWMedicine, @UWIMRP https://t.co/JopmVCdbsk